Stocks · Healthcare · Medical - Devices
DexCom, Inc. DXCM
$85.36 -1.01% Close, Oct 2, 2026 · NASDAQ · Market cap $32.21B
Strong growthHigh qualityInexpensive vs sector
Next earnings report: Oct 29, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Diluted EPS over the last four quarters was $2.53, up 75.7% year over year.
- The shares trade at 33.7× trailing earnings, lower than 86% of the company's own readings over the past five years.
- Earnings beat analyst estimates in each of the last 5 quarters (average surprise over the last four: +11.3%).
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 38%
- EPS growth (TTM, YoY)Top 17%
- FCF growth (TTM, YoY)Top 10%
- Revenue growth, 3-year CAGRTop 36%
- Revenue growth accelerationBottom 46%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 4%
- Gross marginBottom 48%
- Operating marginTop 11%
- Cash conversion (OCF / net income)Top 40%
- Accruals (lower is better)Top 29%
- Net debt / EBITDA (lower is better)Top 40%
- Interest coverTop 4%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 19%
- Free-cash-flow yieldTop 21%
- EBITDA / enterprise valueTop 24%
- Sales / enterprise valueBottom 41%
- P/E vs own 5-year history (lower is better)Top 28%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 41%
- 6-month returnTop 27%
- 1-year return vs S&P 500Top 36%
- Distance from 52-week highTop 11%
- Trend checklist (0–4)Top 39%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 36%
- Consecutive EPS beatsTop 15%
- Share of analysts rating BuyTop 43%
- Upside to consensus price targetBottom 15%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 22%
- Maximum drawdown, 3 yearsTop 36%
- Beta vs S&P 500 (lower is better)Bottom 50%
- Net debt / EBITDA (lower is better)Top 40%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 16.1% | 15.5% | ↓ |
| EPS growth (YoY) | 74.6% | 75.7% | ↑ |
| Gross margin | 58.8% | 62.5% | ↑ |
| Operating margin | 16.0% | 22.9% | ↑ |
| FCF margin | 13.3% | 28.3% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 15.5% | 16.1% | ↓ | Top 38% |
| EPS growth (TTM, YoY) | 75.7% | 74.6% | ↑ | Top 17% |
| Gross margin | 62.5% | 58.8% | ↑ | Bottom 48% |
| Operating margin | 22.9% | 16.0% | ↑ | Top 11% |
| Net margin | 20.1% | 13.3% | ↑ | — |
| Free-cash-flow margin | 28.3% | 13.3% | ↑ | — |
| Return on invested capital | 21.6% | — | Top 4% | |
| Revenue growth, 3-year CAGR | 17.0% | — | Top 36% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.75×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -11.6%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 3.3%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -22.4 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 0.19×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 75.9×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 3.34%
- Shareholder yield
- 3.34%
- Share count change, 1 year
- -4.0%
- Share count change, 3-year CAGR
- -3.2%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Jul 30, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 5
- Beats in the last 8 reports
- 6 of 8
- Average EPS surprise, last 4
- +11.3%
- Average 2-day reaction, last 8
- -0.0%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $91.43
- Target vs current price
- +7.1%
- Analysts with a rating
- 52
- Share rating Buy or Strong Buy
- 81%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 30, 2026 | +14.6% | -0.8% | +10.0% | +18.4% | — |
| Apr 30, 2026 | +20.3% | +3.5% | +4.9% | +25.7% | +27.5% |
| Feb 12, 2026 | +4.6% | -4.5% | +6.0% | -4.2% | -11.1% |
| Oct 30, 2025 | +5.9% | +0.0% | -13.1% | -8.3% | +8.1% |
| Jul 30, 2025 | +8.2% | -0.3% | -15.5% | -14.8% | -20.9% |
| May 1, 2025 | -2.2% | -1.6% | +16.8% | +18.9% | +25.4% |
| Feb 13, 2025 | -6.1% | +0.3% | +6.5% | -18.3% | +1.0% |
| Oct 24, 2024 | +2.3% | +3.3% | -0.9% | +3.8% | +20.2% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 30, 2026 | $0.70 | $0.61 | +14.6% | $1.31B |
| Apr 30, 2026 | $0.56 | $0.47 | +20.3% | $1.19B |
| Feb 12, 2026 | $0.68 | $0.65 | +4.6% | $1.26B |
| Oct 30, 2025 | $0.61 | $0.58 | +5.9% | $1.21B |
| Jul 30, 2025 | $0.48 | $0.44 | +8.2% | $1.16B |
| May 1, 2025 | $0.32 | $0.33 | -2.2% | $1.04B |
| Feb 13, 2025 | $0.45 | $0.48 | -6.1% | $1.11B |
| Oct 24, 2024 | $0.45 | $0.44 | +2.3% | $994.2M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 33.7× | 89.1× | 14th | Top 19% |
| P/E (forward) | 32.0× | — | — | — |
| EV / EBITDA | 20.8× | — | — | Top 24% |
| EV / Sales | 6.54× | — | — | Bottom 41% |
| Free-cash-flow yield | 4.36% | — | — | Top 21% |
| Earnings yield | 2.96% | — | — | Top 19% |
P/E over the past five years
Range 25.4× – 207.7× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +29.2%
- Earnings per share growth (TTM)
- +75.7%
- Change in P/E multiple
- -52.4%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 94
- 50-day average slope (20 days)
- +6.9%
- 200-day average slope (20 days)
- +3.2%
- Distance from 50-day average
- -1.2%
- Distance from 200-day average
- +16.9%
- RSI (14)
- 43.7
- Relative volume
- 0.53×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 39.8%
- Volatility vs own 5-year history
- 38th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.12
- Correlation with S&P 500
- 0.41
- Current drawdown from 1-year high
- -7.6%
- Maximum drawdown, 3 years
- -61.0%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Nov 17, 2021 | Nov 10, 2025 | -66.3% | 998 days | Not yet recovered |
| Oct 26, 2020 | Nov 2, 2020 | -25.4% | 5 days | 74 days (Feb 19, 2021) |
| Apr 28, 2021 | May 13, 2021 | -23.9% | 11 days | 27 days (Jun 22, 2021) |
| Feb 19, 2021 | Mar 18, 2021 | -19.1% | 19 days | 27 days (Apr 27, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $32.21B
- P/E (TTM)
- 33.7
- EPS, diluted (TTM)
- $2.53
- Revenue (TTM)
- $4.97B
- 52-week range
- $54.11 – $92.59
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $2.45B | $2.91B | $3.62B | $4.03B | $4.66B |
| Gross profit | $1.68B | $1.88B | $2.29B | $2.44B | $2.80B |
| Operating income | $265.8M | $391.2M | $597.7M | $600.0M | $911.8M |
| Net income | $216.9M | $341.2M | $541.5M | $576.2M | $836.3M |
| EPS (diluted) | $0.51 | $0.80 | $1.30 | $1.42 | $2.09 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $994.2M | $1.11B | $1.04B | $1.16B | $1.21B | $1.26B | $1.19B | $1.31B |
| Net income | $134.6M | $151.7M | $105.4M | $179.8M | $283.8M | $267.3M | $199.5M | $249.1M |
| EPS (diluted) | $0.34 | $0.38 | $0.27 | $0.45 | $0.70 | $0.68 | $0.51 | $0.64 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $442.5M | $669.5M | $748.5M | $989.5M | $1.44B |
| Capital expenditure | -$389.2M | -$364.8M | -$236.6M | -$358.8M | -$363.5M |
| Free cash flow | $53.3M | $304.7M | $511.9M | $630.7M | $1.08B |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $20.3M | -$535.2M | -$662.1M | -$721.8M | -$471.9M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $1.95B
- Total assets
- $6.46B
- Total liabilities
- $3.83B
- Total debt
- $1.40B
- Net debt
- $293.4M
- Shareholders’ equity
- $2.62B
As of Jun 30, 2026 (filed Jul 30, 2026).
Short interest
- Shares sold short
- 17,263,625
- Days to cover
- 4.98
- Change vs previous report
- -2.1%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Jun 13, 2022
- 4-for-1